|
BZ17044 |
heptyl (4-(N-(5-hexyl-1,3,4-thiadiazol-2-yl)sulfamoyl)phenyl)carbamate |
352441-26-0 |
C22H34N4O4S2 |
482.6598 |
VIEW DETAILS > |
|
BO85356 |
HA protein inhibitor 1 |
346715-10-4 |
C15H15Cl2NO2S |
344.2561 |
VIEW DETAILS > |
|
BZ19649 |
hexyl 2-amino-1-(4-sulfamoylphenyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxylate |
578721-17-2 |
C23H25N5O4S |
467.5407 |
VIEW DETAILS > |
|
BZ20335 |
heptyl 2-(4-nitrophenyl)-1,3-dioxoisoindoline-5-carboxylate |
351993-99-2 |
C22H22N2O6 |
410.4199 |
VIEW DETAILS > |
|
BZ22187 |
hexyl 2-amino-1-(3-methoxypropyl)pyrrolo[3,2-b]quinoxaline-3-carboxylate |
577765-56-1 |
C21H28N4O3 |
384.4720 |
VIEW DETAILS > |
|
BO89675 |
HCV-IN-5 |
491586-35-7 |
C19H17N3O3 |
335.3566 |
VIEW DETAILS > |
|
BZ27071 |
heptyl 4-(3,4-dimethoxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate |
304450-20-2 |
C21H30N2O5 |
390.4733 |
VIEW DETAILS > |
|
AD79709 |
Hydrazinecarboxamide,2-[1-[4-(methylsulfonyl)phenyl]-2-(4-phenyl-1-piperazinyl)ethylidene]- |
104058-03-9 |
C20H25N5O3S |
415.5092 |
VIEW DETAILS > |
|
BZ30023 |
Hypocrellin A |
1924632-08-5 |
C30H26O10 |
546.5214 |
VIEW DETAILS > |
|
BZ30300 |
hexyl 2-[(4-hydroxy-2-oxo-5,6,7,8-tetrahydro-1H-quinoline-3-carbonyl)amino]benzoate |
488121-63-7 |
C23H28N2O5 |
412.4788 |
VIEW DETAILS > |